A clinical research study for Idiopathic Hypersomnia or Narcolepsy
Summary
A clinical research study to evaluate the effectiveness of an
investigational drug(Low-Sodium Oxybate Oral Solution (XYWAV)) in study participants diagnosed with Idiopathic Hypersomnia or Narcolepsy
Eligibility
Eligible gender: Male, Female
Eligible ages: 18 to 75
Inclusion criteria:
You may be eligible to participate in this trial if you are:
- 18 to 75 years of age
- have been diagnosed with Idiopathic Hypersomnia or Narcolepsy
Doctors will also evaluate other criteria to make sure you qualify for the study.
Exclusion criteria:
You may not be eligible to participate in this trial if you:
- have seizure disorder
- female who is breastfeeding or pregnant
Doctors will also evaluate other criteria to make sure you qualify for the study.
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Please contact Dr. Marcus Povitz at mpovitz@ucalgary.ca or call the study coordinator Jill Ranieri at 4036071563 if you would like to learn more about this trial.
Principal investigator:
Marcus Povitz
Clinical trial:
Yes
REB-ID:
REB23-1049